Takahiro Takase
6PUBLICATIONS
8CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 03, 2020
Beneficial effects of switching to denosumab from bisphosphonates or selective estrogen receptor modulators in postmenopausal women with type 2 diabetes and osteopenia/osteoporosis.Arina Miyoshi, Hiraku Kameda, So Nagai
|Nov 01, 2020
Favorable effect of sodium-glucose cotransporter 2 inhibitor, dapagliflozin, on non-alcoholic fatty liver disease compared with pioglitazone.Kyu Yong Cho, Akinobu Nakamura, Kazuno Omori
|Apr 04, 2020
Effects of Palmaria palmata on lipid metabolism and glycemic control in participants with hypercholesterolemia in a randomized double-blind placebo-controlled trial.Takahiro Takase, Akinobu Nakamura, Hideaki Miyoshi
|Oct 13, 2018
Effect of switching from pioglitazone to the sodium glucose co-transporter-2 inhibitor dapagliflozin on body weight and metabolism-related factors in patients with type 2 diabetes mellitus: An open-label, prospective, randomized, parallel-group comparison trial.Kyu Yong Cho, Akinobu Nakamura, Kazuno Omori
|Aug 05, 2018
Improvement in treatment satisfaction after switching from liraglutide to dulaglutide in patients with type 2 diabetes: A randomized controlled trial.Takahiro Takase, Akinobu Nakamura, Chiho Yamamoto
|Jul 03, 2018
Reduction in glucose fluctuations in elderly patients with type 2 diabetes using repaglinide: A randomized controlled trial of repaglinide vs sulfonylurea.Kazuno Omori, Hiroshi Nomoto, Akinobu Nakamura
Pageof 1
